Reuters logo
CORRECTED-Allergan third-quarter revenue rises 11.4 pct
November 1, 2017 / 11:17 AM / 24 days ago

CORRECTED-Allergan third-quarter revenue rises 11.4 pct

(Corrects to add dropped word “profit” in paragraph two)

Nov 1 (Reuters) - Botox-maker Allergan Plc said on Wednesday its quarterly net sales rose 11.4 percent on higher demand for its medical aesthetics products.

Net loss attributable to shareholders was $4.03 billion, or $12.07 per share, in the third quarter ended Sept. 30, compared with a profit of $15.15 billion, or $38.58 per share, a year earlier.

The company said it took an impairment charge of $3.2 billion related to its dry-eye drug Restasis, as well as $1.3 billion in impairment charge related to Teva securities.

Net revenue rose 11.4 percent to $4.03 billion. (Reporting by Tamara Mathias in Bengaluru; Editing by Anil D‘Silva)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below